Marginal note:Testing for phytocannabinoids

• 90 (1) Testing for the quantity or concentration, as the case may be, of THC, THCA, CBD and CBDA must be conducted on each lot or batch of cannabis, other than cannabis plants or cannabis plant seeds, that

  • (a) is or will become a cannabis product; or

  • (b) is or will be contained in a cannabis accessory that is or will become a cannabis product.

• Marginal note:Timing of testing

  (2) The testing must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product.

Marginal note:Testing for contaminants

• 91 (1) Testing for microbial and chemical contaminants — other than residues of a pest control product or its components or derivatives — must be conducted on

  • (a) each lot or batch of cannabis — other than cannabis plants, cannabis plant seeds or edible cannabis — that

    • (i) is or will become a cannabis product, or

    • (ii) is or will be contained in a cannabis accessory that is or will become a cannabis product; or

  • (b) each lot or batch of cannabis — other than cannabis plant seeds — that

    • (i) is used to produce the cannabis referred to in paragraph (a), or

    • (ii) is used to produce edible cannabis that is or will become a cannabis product, or that is or will be contained in a cannabis accessory that is or will become a cannabis product.

• Marginal note:Timing of testing

  (2) The testing on a lot or batch of cannabis must be conducted as follows:

  • (a) the testing referred to in paragraph (1)(a) must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product; and

  • (b) the testing referred to in paragraph (1)(b) must be conducted after the final step in the production process during which the contaminants referred to in subsection (1) could have been introduced or could be concentrated, whichever is later.

• Marginal note:Tolerance limits

  (3) The results of the testing referred to in subsection (1) must enable a determination of whether the contaminants, if any, are or will be within the tolerance limits referred to in subsection 93(3) or 94(2) or section 101.1, as the case may be.

Marginal note:Dissolution and disintegration testing

• 91.1 (1) If cannabis — or a cannabis accessory that contains cannabis — is or will become a cannabis product to which subsection 95(1) applies, testing must be conducted on each lot or batch of the cannabis or cannabis accessory to determine whether the requirements referred to in that subsection are, or will be, met.

• Marginal note:Timing of testing

  (2) The testing must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product.

Marginal note:Testing method

• 92 (1) Testing that is conducted under sections 90 to 91.1 — or to determine whether the applicable requirements in Part 6 are, or will be, met — must be conducted using validated methods on a representative sample of each lot or batch of cannabis or cannabis accessory that contains cannabis.

• Marginal note:Retention period

  (2) A portion of the sample referred to in subsection (1) must be retained for at least one year after the date of the last sale of any portion of the lot or batch.

• Marginal note:Sufficient quantity

  (3) The portion of the sample retained under subsection (2) must be of sufficient quantity to enable a determination of

  • (a) whether the lot or batch meets the requirements of section 81, subsection 93(3), 94(2) or 95(1) or section 101.1, as applicable; and

  • (b) the quantity or concentration of THC, THCA, CBD and CBDA.